Presentation Slides
Back to course
Pdf Summary
deprescribing antipsychotic medications
antipsychotic polypharmacy
off-label indications
adverse effects
patient preferences
recovery-oriented care
good prescribing
pharmacodynamics of antipsychotic medications
pharmacokinetics of antipsychotic medications
evidence-based approach
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By